Search results
Results from the WOW.Com Content Network
The journal was established in 1999 as The American Journal of Pathology, Part B, with Nelson Fausto (University of Washington) as founding editor. [1] [2] [3] According to the Journal Citation Reports, the journal has a 2021 impact factor of 5.341. [4]
Molecular Cancer is a peer-reviewed open-access scientific journal covering all aspects of cancer research. The journal is published by BioMed Central and was established in 2002. The first editor-in-chief was Chi V. Dang, who is also the scientific director of the Ludwig Institute for Cancer Research . [ 1 ]
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
Journal of Bioinformatics and Computational Biology; Journal of Biomedical Informatics; Journal of Computational Biology; Journal of Mathematical Biology; Journal of Theoretical Biology; PLOS Computational Biology; Source Code for Biology and Medicine; Statistical Applications in Genetics and Molecular Biology; Statistics in Biosciences
Journal of Imaging: 2015 2313-433X Journal of Intelligence: 2013 2079-3200 Journal of Low Power Electronics and Applications: 2011 2079-9268 Journal of Manufacturing and Materials Processing: 2017 2504-4494 Journal of Marine Science and Engineering: 2013 2077-1312 Journal of Molecular Pathology: 2020 2673-5261 Journal of Nanotheranostics: 2020 ...
Molecular Oncology is a monthly peer-reviewed open-access medical journal covering research in molecular oncology. It is published by Wiley on behalf of the Federation of European Biochemical Societies. The journal regularly publishes thematic issues with review articles focusing on specific topics of basic, translational, or clinical cancer ...
Journal ranking is widely used in academic circles in the evaluation of an academic journal's impact and quality. Journal rankings are intended to reflect the place of a journal within its field, the relative difficulty of being published in that journal, and the prestige associated with it.
NGS assays, however, are still at an early stage in clinical diagnostics. [48] To do the molecular diagnostic test for cancer, one of the significant issue is the DNA sequence variation detection. Tumor biopsy samples used for diagnostics always contain as little as 5% of the target variant as compared to wildtype sequence.